Viking offers asymmetric upside in GLP-1 drugs with positive trial data, strong cash, and buyout potential despite biotech ...
GDP growth won’t make India a developed country. The asking rate is 12-plus now A surplus monsoon bodes well for agriculture and rural demand this year. GST reforms, which kicked in 10 days ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback